8th Annual

John Vieira Executive Director, Global Brand Strategy, DAIICHI SANKYO, USA

Hannelore Grams Director, Digital Strategy - Europe and Canada, TAKEDA PHARMACEUTICALS, SWITZERLAND

Julie O’Donnell Senior Director and Head, Global Customer Interaction Management, LUNDBECK, DENMARK

Hans Gilhuys Multichannel Marketing Excellence Director, GLAXOSMITHKLINE, UK

Eric Matthews Director, Brand Strategy and Global Interaction, Edoxaban Commercial Team DAIICHI SANKYO EUROPE, GERMANY

Priyanka Trehan UK Channel Lead, Remote Sales/Webcasting, MERCK SHARP DOHME, UK

Guy Yeoman Vice President, Patient Centricity (PaCe) Global Medical Affairs, ASTRAZENECA, UK

David Ziedman Commercial Excellence Director, TEVA PHARMACEUTICALS, NETHERLANDS

Robert Allen Senior Director, Digital Innovations Group ASTRAZENECA, UK

Putting the Ultimate Customer First — Delivering Better Outcomes Through Innovative Digital Initiatives and Patient Centricity

John McCarthy Vice President, Commercial Excellence, ASTRAZENECA, USA

KEYNOTE INDUSTRY ADDRESS:

A SMALL SAMPLE OF OUR KEYNOTE AND EXPERT SPEAKER FACULTY FOR 2016

Davide Bottalico Head of Digital, TAKEDA PHARMACEUTICALS, ITALY

SPONSORED BY:

UCB Pharma outlines how they drafted the digital patient journey and distinguished three playing fields to tailor their approaches

BOEHRINGER INGELHEIM examines the distinction between a changemaker and a technical freak, and provides thoughts about social entrepreneurial thinking for digital experts

ASTRAZENECA AND MEDIMMUNE analyse patient centricity, how to support patients in clinical trials and the role of patient engagement in drug development

LUNDBECK provides insight into content marketing and personalisation — you must leverage cross-channel data to inform a better customer experience, improve targeting and drive more demonstrable ROI

SHIRE illustrates how to reduce customer frustration with digital by rising to meet patients’ needs while adhering to the pharma industry’s regulatory and legal guidances

ASTRAZENECA introduces their pilot initiative for activating social media in Europe

SANOFI describes how they defined and drove a global diabetes mHealth strategy as a key element of diabetes innovation

DAIICHI SANKYO EUROPE presents steps for building a digital ecosystem around your pharma brand

GLAXOSMITHKLINE shows how to embed multichannel marketing into your pharma operating model

F. HOFFMAN-LA ROCHE evaluates successful digital ecosystems that enable omnichannel marketing

3M discusses the visibility of data for sales reps and ways to evaluate true contact points outside of “traditional CLM”

WHAT SETS DIGITAL PHARMA EUROPE APART

It is STILL the ONLY pharmaceutical and medical device marketing conference to be hosted at a pharmaceutical company

It meets the educational and networking needs of BOTH pharma AND medical device organisations

It now includes the hugely successful Social/Innovation Day

200+ senior-level professionals attend each year

Representatives from more than 25 countries come together to embrace the truly global spread of marketing

More than 60% of delegates come from life science companies

Stay ahead of the curve at the largest and only event with a truly innovative and entrepreneurial educational/networking environment that is consistently hosted by a pharmaceutical company

WHAT’S NEW FOR 2016

1-3 MARCH 2016 ALDERLEY PARK, CHESHIRE, UK

VISIT WWW.DIGITALPHARMASERIES.COM/EUROPE FOR MORE INFO

WELCOME TO THE 8TH ANNUAL EDITION OF DIGITAL PHARMA EUROPE!For 2016 we are extremely proud and excited to partner with and host the 8th Digital Pharma Europe at AstraZeneca’s Alderley Park facility in Cheshire, UK. Having previously hosted this event at Bayer Pharma AG (twice), Boehringer Ingelheim, Bristol-Myers Squibb and Merck Serono, the eighth edition marks the sixth time we have held this prestigious conference at a pharmaceutical headquarters.

Since last year’s May 2015 event, there have already been many evolutions in the marketplace and in how life science companies are organising their business models. We are seeing more pharma and medical device companies attempting to move toward an evolved digital health model. Austerity, a dynamic customer behavioral mix, and even the evolution of who your customer is all put pressure on the pharma industry to do business in a different way. It is no longer acceptable to focus solely on overcoming the challenges of today; we as an industry need to start to prepare for tomorrow. As our patients evolve, their demands and expectations, the way they deal with their medical conditions, and even the way their conditions impact other aspects of their lives have all changed. Thus, so too must pharma and medical device companies to help the patient through their journey.

The patient journey/experience engenders many objectives that pharma must consider, including:

• How to assess the innovation landscape today — What can we do to solve current business challenges with innovation, and how can we incorporate innovation teams with marketing, IT, regulatory, and even R&D?

• The need for an overarching, global consumer engagement strategy — What is the level of innovation needed and how can we differentiate with offerings, not just price?

• Value beyond the pill — Where does “beyond” take us from a tactical perspective?

• How to bridge the gap between “pharma speed” and “digital speed” — How and what can we leverage from other sectors?

• Whether pharma can move past the absence of a “fail fast” mentality — Can pharma adopt a company culture that is less risk averse and lends itself to improved operational efficiency to allow for more innovative tools and offerings?

• Execution methods — How can the life sciences industry balance speed, relevance, demands and utility to get where we want to be?

It also raises a very important question: How can we launch for a solution, not just a product?

This conference will profile best-in-class case studies and senior-level discussions that will allow you to leverage solutions, technologies and tactics to prepare for tomorrow. It will also analyse issues such as reducing costs, mastering MCM, improving the uses and effectiveness of new digital marketing techniques, harnessing analytics to drive improved ROI/customer satisfaction, and reforming SFE.

Now in its eighth year, Digital Pharma Europe has become the most comprehensive content delivery device, knowledge-sharing platform and networking event in the European life sciences digital marketing space. We at ExL Events and AstraZeneca invite you to join us at this conference to discover the direction digital marketing will take in 2016 and beyond.

Warren DrysdaleSenior Conference DirectorExL Events

Jayson Mercado Head of Digital Events ExL Events

JOIN THE CONVERSATION ONLINE

@DigitalPharma

#DigPharm

Digital Pharma

digitalblog.exlpharma.com

SPONSORSHIP AND EXHIBITION OPPORTUNITIES

Do you want to spread the word about your organisation’s solutions and services to potential clients who will be attending this event? Take advantage of the opportunity to exhibit, underwrite an educational session, host a networking event or distribute promotional items to attendees. ExL Events will work closely with you to customise a package that will suit all of your needs. To learn more about these opportunities, contact Jayson Mercado, Head of Digital Events, at jmercado@exlevents.com.

VENUE INFORMATION

Alderley Park Conference CenterAlderley Edge, CheshireSK10 4TG

VISIT WWW.DIGITALPHARMASERIES.COM/EUROPE FOR MORE INFO

Robert AllenSenior Director, Digital Innovation GroupASTRAZENECA, UK

Matthew BonamPharmaceutical Project Director, Intelligent PharmaceuticalsASTRAZENECA, UK

Davide BottalicoHead of DigitalTAKEDA PHARMACEUTICALS, ITALY

Christophe Bureau Vice President Strategic InnovationSTEVANATO GROUP, ITALY

Rebecca CarsonHead of Research ServicesBRANDWATCH, UK

Ian CockerhamHOPE Programme FacilitatorMACMILLAN CANCER SUPPORT

Chris CrockfordCEOCARDIOCITY, UK

Herve DumasPatient Care Solution LeadUCB PHARMA, SWITZERLAND

Zoe DunnPrincipalHALE ADVISORS, USA

Marie Ennis-O’ConnorOwnerHealthcare Social Media Monitor

Jane FangR&D IS Head for Clinical BiologicsMEDIMMUNE, USA

Mohanad ForsGlobal Director, Digital Marketing/Digital Innovation- OphthalmologyNOVARTIS, SWITZERLAND

Hans GilhuysMultichannel Marketing Excellence DirectorGLAXOSMITHKLINE, UK

Hannelore GramsHead of Digital Strategy, Europe and CanadaTAKEDA PHARMACEUTICALS, SWITZERLAND

Shwen GweeDirector, Digital Customer InsightsBIOGEN, USA

Delphine HajajiDirector of IT and Global Head of DigitalUCB PHARMA, BELGIUM

Ben HeadDigital Lead, Commercial and Business OperationsMERCK SHARP DOHME, UK

Klaas-Pieter JimminkGlobal Marketing Director – New ChannelsMOLNYCKE, USA

John McCarthyVice President, Commercial ExcellenceASTRAZENECA, USA

Daniel MathewsLife Science PartnerEY, UK

Eric MatthewsDirector Brand Strategy and Global Interaction Edoxaban Commercial TeamDAIICHI SANKYO EUROPE, GERMANY

Christophe MeugnierSenior Director, Oncology Launch Readiness and Marketing OperationsASTRAZENECA, JAPAN

Brigid OchsnerGlobal Vice PresidentEAGLE PRODUCTIVITY

Julie O’DonnellSenior Director and Head, Global Customer Interaction ManagementLUNDBECK, DENMARK

Manuela PastoreLeader, Global Social and Shared Value Initiatives, “Making More Health”BOEHRINGER INGELHEIM, GERMANY János Pénzes, M.D.International eMarketing ManagerInternational MarketingGEDEON RICHTER PLC., HUNGARY Alexandra PetersonSenior Vice President, Healthcare Practice DirectorMAKOVSKY, USA

Koen Petit IT Manager, Solution Services, Europe and CanadaELI LILLY, BELGIUM

Kay RispeterMultichannel Marketing & Customer Engagement LeadMSD SHARP & DOHME GMBH

Nuno RodriguesDigital and Multichannel ManagerROCHE, PORTUGAL

Guy ShauliGlobal Director, Social MediaASTRAZENECA, UK

Joe ShieldsSenior Director, Strategy and Program Management Global Digital Strategy and InnovationASTRAZENECA, USA

Pamela SpenceGlobal Client Service Partner: PharmaceuticalsEY, UK

Len StarnesFounder and ConsultantLEN STARNES DIGITAL CONSULTING, GERMANY

Priyanka TrehanUK Channel Lead, Remote Sales/WebcastingMERCK SHARP DOHME, UK

John VieiraExecutive Director, Global Brand StrategyDAIICHI SANKYO, USA

Guy YeomanVice President, Patient Centricity (PaCe)Global Medical AffairsASTRAZENECA, UK

David ZiedmanCommercial Excellence DirectorTEVA PHARMACEUTICALS, NETHERLANDS Erik van der Zijden BSc MBACEO and Co-founderSYNAPPZ MEDICAL APPS

THE ESTEEMED AND STILL-EXPANDING SPEAKER FACULTY FOR 2016:

VISIT WWW.DIGITALPHARMASERIES.COM/EUROPE FOR MORE INFO

The 8th Digital Pharma Europe takes actionable content and education to new levels. The customer journey and the path to customer excellence for the future begins now. To start on this course, however, certain trends must be addressed:

The “centricity model”: moving from brand-centric customer-centric thinking: Marketplace expectations have changed. The customer has more control, which has increased the importance of building value and value add.

Sales reps are now a “channel”: As we move away from a sales rep-centric business model, we must orchestrate and integrate all channels.

The role of data insights: The industry has been able to collect and aggregate vast sums of data. However, how pharma and medical device companies can utilise and leverage this information in a meaningful way is now an obstacle. How do you determine what is valuable and how do you convert valuable information into insight and action?

Performance accountability: In the ever-evolving healthcare landscape, there is increasing pressure on budgets and a higher expectation from senior management to demonstrate ROI.

More specifically:

Social media: It’s not going away! While DTC is prohibited in Europe, global teams need to understand how to navigate all aspects of engaging consumers online, including pharmacovigilance, monitoring, content solicitation, access to information, privacy and data security. Understand strategies for engaging patients via social media.

A more applied approach to aggregating data to leverage in a meaningful way: Realise how pharma and medical device companies can parse through vast data streams and understand exactly what is valuable, bridge the gap between wearables + data + devices, and understand how to effectively integrate and utilise predictive analytics techniques and predictive modeling.

Consumer and physician interfacing/interaction/experience management: Improve the “how to” of interacting with patients and the identification of which digital tools to use. Leverage examples and set yourself up on the path to customer excellence and the engagement techniques of the future.

Digital innovation and the value proposition for life sciences: Review wearable technologies, novel customer interfaces and touch points. Analyse “connected digital health” and how consumers, their phones and their other connected devices will change the way you do business.

Core competencies and a company road map for digital transformation in line with your specific organisational business objectives: Develop robust business models that foster quicker collaboration between divisions, allow for decision-making processes to be made at lower levels of seniority, and increase accountability in a cost-effective manner.

THE 8TH ANNUAL DIGITAL PHARMA EUROPE IS THE LEADING EDUCATIONAL PLATFORM FOR THE ENTIRE EUROPEAN LIFE SCIENCES COMMUNITY.

ASK YOURSELF: “WHAT EXACTLY WILL I LEARN?”

HOTEL INFORMATION A small block of guest rooms will be held at Mottram Hall:

Mottram HallWilmslow RoadMottram St AndrewPrestbury, Cheshire, UK SK10 4QT

To make reservations please call +44 0845 074 0060 and request the negotiated rate for ExL’s 8th Digital Pharma Europe. You may also make reservations by emailing stay@qhotels.co.uk and requesting the negotiated rate for ExL’s 8th Digital Pharma Europe. The group rate is available until 1 February 2016. Please book your room early as rooms available at this rate are limited.

There will be limited shuttle service from Mottram Hall to Alderley Park each morning before the meetings and back to Mottram Hall at the end of the meetings each day.

*ExL Events, Inc. is not affiliated with Exhibition Housing Management (EHM)/Exhibitors Housing Services (EHS) or any third-party booking agencies, housing bureaus, or travel and events companies. In the event that an outside party contacts you for any type of hotel or travel arrangements, please disregard these solicitations and kindly email us at info@exlevents.com. ExL has not authorised these companies to contact you and we do not verify the legitimacy of the services or rates offered. Please book your guest rooms through ExL’s reserved guest room block using the details provided.

VISIT WWW.DIGITALPHARMASERIES.COM/EUROPE FOR MORE INFO

8:00 Registration and Morning Coffee

DIGITAL TECHNOLOGIES DAY

8:45 Opening Remarks from the Chair

Pamela Spence, Global Client Service Partner: Pharmaceuticals, EY, UK

9:00 CASE STUDY Are You a Real Changemaker or Just a Technical Freak? Thoughts About Social Entrepreneurial Thinking for Digital Experts

› Assess what digital marketers can learn from social entrepreneurship

Manuela Pastore, Leader, Global Social and Shared Value Initiatives, “Making More Health,” BOEHRINGER INGELHEIM, GERMANY

9:30 CASE STUDY Five Things I Wish I Knew Before Planning My Pharma Social Media Campaign (The Last One Will Amaze You!)

Guy Shauli, Global Director, Social Media.ASTRAZENECA, UK

10:00 CASE STUDY Patient Apps: Are They Really for Patients?

Mohanad Fors, Global Director, Digital Marketing/Digital Innovation - Ophthalmology, NOVARTIS, SWITZERLAND

10:30 Morning Networking Break

11:00 CASE STUDY From Formula1 to Looking After Number1. How Technology Will Change the Consumer Market

› History of telemetry from the Space Race to Formula1 › What happens to your physiology if money is no object? › You service your car more times than you service your heart › How the march to proactive healthcare will empower the

pharmacists › What I believe the future looks like

Chris Crockford, CEO, CARDIOCITY, UK

11:30 PATIENT CASE STUDY Can Patients Be Innovators?

In an era of patient centricity and a desire to play an ever increasing role in their health can patients be true innovators? I will explore how patients are at the forefront of adopting new technologies and how patients have a growing desire to engage with pharma. Are patients the greatest under utilised resource in healthcare? › What happens to your physiology if money is no object › You service your car more times than you service your heart › How the march to proactive healthcare will empower

pharmacists › What Mr. Crockford believes the future looks like

Michael Seres, CEO and Patient Entrepreneur, 11 HEALTH & TECHNOLOGIES, UK

12:00 PATIENT CASE STUDY To Do Is To Be / To Be Is To Do / Do Be Do Be Do

In an era of patient centricity and a desire to play an ever increasing role in their health can patients be true innovators? I will explore how patients are at the forefront of adopting new

technologies and how patients have a growing desire to engage with pharma. Are patients the greatest under utilised resource in healthcare? › A patient does not fit into a box (except at the very end –

R.I.P.) › Past / present / future … no longer relevant – to a patient,

to anyone? › Why do we do what we do? (anyone, everyone?) › Who are patients? Are we all patients? If not why not? Could

we be? › What is patient centricity (Is it the same as person

centricity)?

Ian Cockerham, HOPE Programme Facilitator MACMILLAN CANCER SUPPORT

12:30 CASE STUDY AstraZeneca’s Implementation of a Governance Model to Manage Digital Assets Used Across The Company

› Learn how AstraZeneca set up and evolved an industry leading global digital governance model for digital assets developed for physicians, patients and new recruits

› Discuss ways to manage the life cycle of digital assets from inception to decommissioning

› Analyze how a centralised service has helped improve compliance with internal policies and efficiencies within different teams

Jessica Pfennig, Global Digital Governance Director,ASTRAZENECA, USA

13:00 DIGITAL MINI WORKSHOP Build Your Own Digital Ecosystem — What is the Path to Success?

While you’ll hear great theories and case studies from industry experts, many of you will still be challenged to bring that learning back to your organisations in an actionable format. In this “mini” workshop, we’ll help you evaluate your own digital mix and determine where you can improve/enhance/repair/optimise it for success! › Organisational readiness: Does digital have a place in the

culture of your organisation? › Your digital mix: What does your ecosystem look like? › Connections: Where are the gaps and opportunities? › Functionality: How do you know when you succeed? › What’s next: How do you implement?

Zoe Dunn, Principal, HALE ADVISORS, USAJohn Vieira, Executive Director, Global Brand Strategy, DAIICHI SANKYO, USA

14:00 Networking Luncheon

SOCIAL/INNOVATION DAY15:00 Opening Remarks from the Chair

Shwen Gwee, Director, Digital Customer Insights, BIOGEN, USA

FIRESIDE CHAT AFTERNOON SESSIONSFireside chats follow a set format: In 20 minutes, speakers present the innovative strides their pharma/medical device companies make on specific social platforms — the places where actionable initiatives can be leveraged in the healthcare space.

Following their presentations, speakers will take part in 20-minute discussions about the challenges and benefits of leveraging these platforms as tools for engaging customers in healthcare, the feedback they have received, and ultimate practical successes.

17:20 Close of Digital Technologies and

DIGITAL TECHNOLOGIES AND SOCIAL/INNOVATION DAY 1 MARCH 2016

MAIN CONFERENCE DAY ONE 2 MARCH 2016

7:45 Registration and Morning Coffee

8:30 Opening Remarks from the Chair

Brigid Ochsner, Global Vice President, EAGLE PRODUCTIVITY SOLUTIONS, USA

8:45 INDUSTRY WELCOME ADDRESS Keynote Address from AstraZeneca and Industry Overview for 2016

John McCarthy, Vice President, Commercial Excellence, ASTRAZENECA, USA

9:15 CASE STUDY Digital Disruptive Innovation in the Pharmaceutical Industry — the Future of Digital Healthcare

› Digital: disrupting the foundations of business models across all major industries

› Digital technologies: changing the healthcare value chain starting with the patient

› Pharmaceutical companies: shift toward unlocking value by applying digital technologies to our business models

› Network of partnerships: a requirement for success in digital health

› How we have approached digital disruption at Takeda — lessons learned

Hannelore Grams, Head of Digital Strategy, Europe and Canada, TAKEDA PHARMACEUTICALS, SWITZERLAND

9:45 CASE STUDY Drafting the Digital Patient Journey: How UCB Distinguishes Three Digital Playing Fields and Gives Them Different Approaches

› Mature digital projects › Emerging projects › The experimental zone

› Ways to foster cross-functional collaboration

Delphine Hajaji, Director of IT and Global Head of Digital, UCB PHARMA, BELGIUM

10:15 CASE STUDY Patient Centricity: How to Support Patients in Clinical Trials and Understand the Role of Patient Engagement in Drug Development

Robert Allen, Senior Director, Digital Innovation Group, ASTRAZENECA, UKJane Fang, R&D IS Head for Clinical Biologics,MEDIMMUNE, USA

10:45 Morning Networking Break

11:15 CASE STUDY Content Marketing and Personalisation — Leveraging Cross-Channel Data to Inform a Better Customer Experience, Improve Targeting and Drive More Demonstrable ROI

Julie O’Donnell, Senior Director and Head, Global Customer Interaction Management, LUNDBECK, DENMARK

11:45 PANEL DISCUSSION Making Social Media Work for Pharma

Explore the evolution of social media in the pharmaceutical space - from fully verboten to the robust, integrated social campaigns some brands now run — in order to unearth how to make social media work as hard as it possibly can for pharma brands. Not only must regulatory parameters be considered, but disease state-specific nuances, such as the level of engagement by the patient population with the condition, also play a role in determining how best to frame a social media initiative. Regional differences further complicate matters; what works in one country may not work in another due to cultural preferences, differing guidelines (or lack of guidelines) for how pharma can engage in social spaces, and other regional or country–specific considerations. This session will review case studies (the good, the bad and the ugly) and discuss best practices for implementing social media programmes in various healthcare categories and across geographies.

Moderator:Alexandra Peterson, Senior Vice President, Healthcare Practice Director, MAKOVSKY, USA

12:15 CASE STUDY PaCe’ing Digital Interactions

› What is and is not Patient Centricity › The opportunity to impact clinical research › The opportunity to deliver effective patient services › AZ case studies

Guy Yeoman, VP Patient Centricity (PaCe),Global Medical Affairs, ASTRAZENECA, UK

12:45 PATIENT CASE STUDY Patient 2.0: Wired For Health

Web 2.0 technologies and applications have radically transformed established notions of patienthood. Patients are now occupying a pivotal space within connections to other patients, carers, and healthcare professionals. A defining characteristic of Web 2.0 is user-generated content which in turn generates collective intelligence. This has given rise to a new age of networked knowledge; meaning knowledge - ideas, information, wisdom – has broken out of its traditional clinical confines and now exists in a hyper-connected online state. This presentation will explore how the industry can better understand this changing healthcare paradigm and position itself to contribute meaningfully to the growing ePatient movement.

Marie Ennis-O’Connor, Owner, HEALTHCARE SOCIAL MEDIA MONITOR

13:15 CONFERENCE KEY THEME PANEL DISCUSSION How Does Pharma Actually Deliver on Really Being Patient-Centric in Their Marketing and Business Model

Discuss how industry organisations can build a business that can: › Put patients first › Think patient › Empower the engaged patient › Truly get why patients matter › Understand patients — “The Centre of What We Do” › Deliver on the patient experience › Go beyond the patient — people › Recognise that every patient is a person at heart

Moderator:Len Starnes, Founder and Consultant, LEN STARNES DIGITAL CONSULTING, GERMANY Panelists:Marie Ennis-O’Connor, Owner, HEALTHCARE SOCIAL MEDIA MONITORMichael Seres, CEO and Patient Entrepreneur,11 HEALTH & TECHNOLOGIES, UKIan Cockerham, HOPE Programme Facilitator,MACMILLAN CANCER SUPPORT

MAIN CONFERENCE DAY ONE 2 MARCH 201614:00 Strolling Networking Luncheon

15:00 CASE STUDY From Beyond the Pill to Integrated Patients’ Care Pathway Solutions for Chronic Diseases

Chronic diseases often need specialist care, are cost-intense and long-term treatments with common non-drug related side effects such as depression, fatigue and lack of adherence limiting the ability for governmental and private payers to pay for servicesAs a consequence, healthcare professional not only need to deliver the most appropriate medication in terms of efficacy and safety, but are more and more asked to increase the productivity and efficiency of care delivery, leading to the need for a greater integration of care into a more robust patients’ care pathway. As part of the health ecosystem, pharma and medical devices companies will have to answer the following questions. › How to best define a Patients’ Care Pathway and map the key

stakeholders? › How pharma companies could understand Patients’ Care

Pathway pinch points and facilitate broader integration of Care Pathway?

› How to keep patients at the center point of the pathway and how to leverage digital?

Herve Dumas, Patient Care Solution Lead, UCB PHARMA, SWITZERLAND

15:30 CASE STUDY The Customer Journey Is Not Just One Channel — How to Link Channels, Themes and Journeys

David Ziedman, Commercial Excellence Director,TEVA PHARMACEUTICALS, NETHERLANDS

16:00 CASE STUDY How to Be Patient-Centric in a Non-Patient-Centric Market Christophe Meugnier, Senior Director, Oncology Launch Readiness and Marketing Operations, ASTRAZENECA, JAPAN

16:30 Afternoon Networking Break

17:00 CASE STUDY Defining and Driving a Global Diabetes mHealth Strategy as a Key Element of Diabetes Innovation

› Understand the diabetes challenge › Walk through a day in the life of a person with diabetes › Explore opportunities from mHealth › Analyse why traditional pharma approaches to mHealth do not

work › Pinpoint what is needed to successfully tackle the diabetes

challenge › Examine the MyStar brand case study

Milena Saleh, Director of mHealth, SANOFI, GERMANY

17:30 PANEL DISCUSSION Customer Expectations Have Changed: Finding YOUR Path to Customer Excellence

Has your business model kept up with your customer base? The time has come to explore the shift from brand centricity to customer centricity, the evolution of the sales rep as a channel, and the role of data insights and performance accountability. › Improve the “how to” of interacting with patients and determine

which digital tools to use › Discern how the new Apple Healthbook will impact interfacing

and the development of advanced health apps › Process how to better deal with incoming requests for

information from customers › Manage customer interactions › Learn about customer-interfacing digital tools and channels › Develop a multichannel integrated content strategy

Moderator:Joe Shields, Senior Director, Strategy and Program Management, Global Digital Strategy and Innovation,ASTRAZENECA, USA

Panelists:Nuno Rodrigues, Digital and Multichannel Manager, ROCHE, PORTUGALKay Rispeter, Multichannel Marketing & Customer Engagement Lead, MSD SHARP & DOHME GMBHDaniel Mathews, Life Science Partner, EY, UK

18:15 Conclusion of Day One and Networking Cocktail Reception

Sponsored By:

Follow Us@DigitalPharma

#DigPharm

@L_Naponiello Great contributions from all around the world to create value for all the stakeholders in #healthcare

@Aghenor  Great experience @digitalpharma! I got several insights from passionate people.

@eWizard_app It is a really active dialogue on #DigPharm today!

@drpenzesjanos ...great 3 days, big thanks [to] everyone for the valuable discussions and sharing ideas!

@TommyAnnfeldt David St. Denis is right to the point! Bulls eye, spot on to the point on the challenges we face in the #pharmaindustry #DigPharm

VISIT WWW.DIGITALPHARMASERIES.COM/EUROPE FOR MORE INFO

MAIN CONFERENCE DAY TWO 3 MARCH 2016

7:45 Registration and Morning Coffee

8:25 Opening Remarks from the ChairBrigid Ochsner, Global Vice President, EAGLE PRODUCTIVITY SOLUTIONS, USA

8:30 CASE STUDY Establishing a Digital Ecosystem: A Three-Wave Process

› Learn how to establish an appropriate mix of digital properties for your customers

› Determine how to interlink properties › Plan how to link with offline activities › Discover how to align European efforts with local efforts

Eric Matthews, Director Brand Strategy and Global Interaction, Edoxaban Commercial Team, DAIICHI SANKYO EUROPE, GERMANY

9:00 CASE STUDY The Anatomy of Digital Ecosystems: How to Build an Amazing digital Machine

› Address the difficult nature of building a pharma digital brand plan and recognise that the exercise is not a consequence of traditional brand plans

› Plot digital activities to align with offline initiatives › Work to build a digital ecosystem in which all activities are linked to

each other › Review a practical five-step course of action for creating your

ecosystemDavide Bottalico, Head of Digital, TAKEDA PHARMACEUTICALS, ITALY

9:30 CASE STUDY Embedding Multichannel in the Pharma Operating Model

Hans Gilhuys, Multichannel Marketing Excellence Director,GLAXOSMITHKLINE, UK

10:00 Morning Networking Break

10:30 CASE STUDY Customer Engagement at MSD

Priyanka Trehan, UK Channel Lead, Remote Sales/Webcasting, MERCK SHARP DOHME, UK Ben Head, Digital Lead, Commercial and Business Operations, MERCK SHARP DOHME, UK

11:00 CASE STUDY Three Years – Three Lessons: A Mobile Health Application Case Study

› Why develop a mobile app? – strategic considerations › Combining external and internal stakeholder needs for long term

sustainability › Numbers and market insights: what is behind an app with more

than 100,000 downloads? › Lessons learned about development, promotion and integration

János Pénzes, M.D., International eMarketing ManagerInternational Marketing, GEDEON RICHTER PLC., HUNGARY

11:30 CASE STUDY The Journey Toward a New Way to Engage Online with Healthcare Professionals

› Align on global requirements with a multinational team › Design together with the customer › Build across geographies › Discuss the present state of engagement

Koen Petit, IT Manager, Solution Services, Europe and Canada,ELI LILLY, BELGIUM

12:00 Packaging As a Media Channel: Better Than the Internet to Reach Out To Patients

Chronic diseases with the largest prevalence actually involve a minority population at the scale of majority social media networks. Using the internet to reach out to patients is an intrinsic economical nonsense, as the costs of digital customer acquisition are prohibitive. As a result, communities of patients around a given chronic disease are highly fragmented, and difficult to leverage for pharma companies. We are presenting an alternative channel using the very packaging of pharma product as a very effective channel to reach out to patients with very high efficacy, worldwide, enabling marketing and patient management programs at impressively low cost.

Christophe Bureau, Vice-President Strategic Innovation, STEVANATO GROUP, ITALY

12:30 CASE STUDY Digital Health and How We Can Use New Technologies Connected to Our Medications to Improve Outcomes

Matthew Bonam, Pharmaceutical Project Director, Intelligent Pharmaceuticals, ASTRAZENECA, UK

13:00 Strolling Networking Luncheon 14:00 CASE STUDY Digital Transformation: How to Start the Journey and What Is Important to Get Traction

Klaas-Pieter Jimmink, Global Marketing Director – New Channels, MOLNYCKE, USA

14:30 Digital + Patients = ∆Health Outcomes? › What are the challenges and learning from digital initiatives in

healthcare? › Do we need a more holistic approach, broader than patient-centric

and digital? › What can we learn from other sectors? › Observations from our experience of helping clients to add value

through improved health outcomes Charlie Buckwell, CEO, MCCANN COMPLETE MEDICAL AND DOUBLE HELIX

15:00 Afternoon Networking Break

15:30 CASE STUDY How to Engage Patients via Social Media in Compliance with International Guidances and Regulations

› Understand factors contributing to the international pharma community’s hesitance to utilize social mediA

› Compliantly engage patients via social media and mitigate associated risks

› Develop internal procedures to address social media considerations such as PV monitoring/reporting, access to information, and data security

› Gain insight into FDA’s most recent thinking on social media Dan Zavodnick, Regulatory Counsel, ALLERGAN, USA

16:00 Closing Remarks from the Chair and Close of Conference

QUESTIONS? COMMENTS?

Do you have a question or comment you would like to be addressed at this event? Would you like to get involved as a speaker or discussion leader? Please email Senior Conference Director Warren Drysdale at wdrysdale@exlevents.com.

VISIT WWW.DIGITALPHARMASERIES.COM/EUROPE FOR MORE INFO

TARGET AUDIENCE

WHO SHOULD ATTEND DIGITAL PHARMA EUROPEThis conference is designed specifically for professionals from the pharmaceutical, biotechnology and medical device industries whose responsibilities include:

DMarketing DDigital Marketing DDigital Strategy D Integrated Marketing DMultichannel Marketing DSocial Media DPatient Care Solutions DPatient Centre of Excellence DPatient Engagement DMobile Marketing DeMarketing DeBusiness DGlobal Marketing

D Interactive Services DChannels D Innovation DCustomer Experience DCustomer Engagement Capabilities DField Force/SFE DBrand Management DProduct Management DStrategic Operations DPR/Communications DNew Media DAdvertising and Promotions

D IT DRegulatory Affairs DRegulatory Advertising DLegal Counsel and MLR DCompliance

Together with: DPhysician Networks DePatients DRegulators DDigital Agencies DTechnology Providers

MEDIA PARTNERS

DIGITAL PHARMA HIGHLIGHTSClick the link below to see what Digital Pharma East brought to the table this year!

BY INDUSTRY

21%Agency 8%

Consultant

3%Academic

45%Pharma/Biotech/Biopharma/Medical Device

23%Digital/Technology Solutions

BY LEVEL 4%C-Suite

13%VP/SVP

35%Manager

28%Director

20%Senior Director

TARGET AUDIENCE

The eJournal for leaders and communicators in healthcare

VISIT WWW.DIGITALPHARMASERIES.COM/EUROPE FOR MORE INFO

REGISTRATION FEESPHARMA, BIOTECH AND MED DEVICE RATES

All Access: (Conference and Digital Technologies and Social/Innovation Day)

£1,595 £1,795 £1,895

Conference Only £1,295 £1,495 £1,595

AGENCY, CONSULTANT AND SOLUTION PROVIDER RATES

All Access: (Conference and Digital Technologies and Social/Innovation Day)

£1,695 £1,895 £1,995

Conference Only £1,395 £1,595 £1,695

EARLY BIRD RATES BEFORE 15 JANUARY 2016

STANDARD RATES AFTER 15 JANUARY 2016

ONSITE RATES

WAYS TO REGISTER

TERMS AND CONDITIONS: By registering for an ExL Events, Inc. (“ExL”) event, you agree to the following set of terms and conditions listed below:

REGISTRATION FEE: The fee includes the conference‚ all programme materials‚ and designated continental breakfasts‚ lunches and refreshments.

PAYMENT: Make checks payable to ExL Events, Inc. and write C791 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full by the conference date. Any discount applied cannot be combined with any other offer and must be paid in full at the time of order. Parties must be employed by the same organisation and register simultaneously to realise group discount pricing options.

**Please Note: There will be an administrative charge of £300 to substitute, exchange and/or replace attendance badges with a colleague within five business days of any ExL conference.**

CANCELLATION AND REFUND POLICY: If you cancel your registration for an upcoming ExL event, the following policies apply, derived from the Start Date of the event:

• Four weeks or more: A full refund (minus a £295 processing fee) or a voucher to another ExL event valid for 12 months from the voucher issue date.

• Less than four weeks: A voucher to another ExL event valid for 12 months from the voucher issue date.

• Five days or less: A voucher (minus a £395 processing and documentation fee) to another ExL event valid for 12 months from the voucher issue date.

To receive a refund or voucher, please email cancel@exlevents.com or fax your request to +1 888-221-6750.

CREDIT VOUCHERS: Credit vouchers are valid for 12 months from date of issue. Credit vouchers are valid toward one (1) ExL event of equal or lesser value. If the full amount of said voucher is not used at time of registration, any remaining balance is not applicable now or in the future. Once a credit voucher has been applied toward a future event, changes cannot be made. In the event of cancellation on the attendees’ behalf, the credit voucher will no longer be valid.

ExL Events, Inc. does not and is not obligated to provide a credit voucher to registered attendee(s) who do not attend the event they registered for unless written notice of intent to cancel is received and confirmed prior to the commencement of the event.

SUBSTITUTION CHARGES: There will be an administrative charge of £300 to substitute, exchange and/or replace attendee badges with a colleague occurring within five business days of the conference.

ExL Events reserves the right to cancel any conference it deems necessary and will not be responsible for airfare‚ hotel or any other expenses incurred by registrants.

ExL Events’ liability is limited to the conference registration fee in the event of a cancellation and does not include changes in programme date‚ content‚ speakers and/or venue.

*The opinions of ExL’s conference speakers do not necessarily reflect those of the companies they represent, nor ExL Events, Inc.

Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, significant effort to find a suitable replacement will be made. The content in ExL slide presentations, including news, data, advertisements and other information, is provided by ExL’s designated speakers and is designed for informational purposes for its attendees. It is NOT INTENDED for purposes of copywriting or redistribution to other outlets without the express written permission of ExL’s designated speaking parties. Neither ExL nor its content providers and/or speakers and attendees shall be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. EXL EVENTS, INC. EXPRESSLY DISCLAIMS ALL WARRANTIES, EXPRESSED OR IMPLIED, AS TO THE ACCURACY OF ANY CONTENT PROVIDED, OR AS TO THE FITNESS OF THE INFORMATION FOR ANY PURPOSE. Although ExL makes reasonable efforts to obtain reliable content from third parties, ExL does not guarantee the accuracy of, or endorse the views or opinions given by any third-party content provider. ExL presentations may point to other websites that may be of interest to you, however ExL does not endorse or take responsibility for the content on such other sites.

GROUP DISCOUNT PROGRAMMES Offers cannot be combined. Early bird rates do not apply. To find out more on how you can take advantage of these group discounts, call +1 866-207-6528.

Save 15% Can only send three? You can still save 15% off of each registration.

Save 25% For every three simultaneous registrations from your company, you will receive a fourth complimentary registration to the programme (must register four at one time).

www.digitalpharmaseries.com/europe

registration@exlevents.com

+1 212-400-6240

ExL Events, Inc. 494 8th Avenue, Fourth FloorNew York, NY 10001